Relationship Between Procalcitonin Serum Levels and Functional Outcome in Stroke Patients

Cellular and Molecular Neurobiology

Volumn 35, Issue 3, 2015, Pages 355-361

  Deng, Wen Jing ^a   Shen, Rui Le ^b   Li, Meng ^a   Teng, Jun Fang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute ischemic stroke; Functional outcome; Procalcitonin; Short term

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FUNCTIONAL STATUS; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANKIN SCALE; STROKE PATIENT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CONVALESCENCE; ETHNOLOGY; FOLLOW UP; MIDDLE AGED; STROKE; TREATMENT OUTCOME;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; CALCITONIN; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; RECOVERY OF FUNCTION; STROKE; TREATMENT OUTCOME;

EID: 84925539863     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-014-0131-0     Document Type: Article

References (32)

1. Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
2. Bonita R (1988) BR (1988) Modification of Rankin Scale: recovery of motor function after stroke. Stroke 19:1497–1500
3. Bonita R, Mendis S, Truelsen T et al (2004) The global stroke initiative. Lancet Neurol 3:391–393
4. Broderick JP, Brott TG, Duldner JE et al (1993) (1993), Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 24:987–993
5. Brott T, Marler JR, Olinger CP et al (1989) Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke 20:871–875
6. Castelli GP, Pognani C, Meisner M et al (2004) Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 8:R234
7. Chang L, Yan H, Li H et al (2014) N-terminal probrain natriuretic peptide levels as a predictor of functional outcomes in patients with ischemic stroke. NeuroReport 25:985–990
8. Emerging Risk Factors Collaboration (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375:132
9. Fluri F, Morgenthaler NG, Mueller B et al (2012) Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke. PLoS ONE 7:e48309
10. Fuentes B, Castillo J, San José B et al (2009) The prognostic value of capillary glucose levels in acute stroke: the GLycemia in acute stroke (GLIAS) study. Stroke 40:562–568
11. Harbarth S, Holeckova K, Froidevaux C et al (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164:396–402
12. ICD-9-CM: International Classification of Diseases 9th Revision Clinical Modification[M] (1980) US Department of Health and Human Services, Public Health Service, Health Care Financing Administration
13. Katan M, Moon YP, DeRosa J et al (2014) Procalcitonin, copeptin and midregional pro-atrial natriuretic peptide as markers of ischemic stroke risk: the northern Manhattan study. Stroke 45(Suppl 1):A54–A54
14. Luyt CE, Guérin V, Combes A et al (2005) Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 171:48–53
15. Markaki I, Franzén I, Talani C et al (2013) Long-term survival of ischemic cerebrovascular disease in the acute inflammatory stroke study, a hospital-based cohort described by TOAST and ASCO. Cerebrovasc Dis 35:213–219
16. Maruna P, Nedelnikova K, Gurlich R (2000) Physiology and genetics of procalcitonin. Physiol Res 49:S57–S62
17. McGrane S, Girard TD, Thompson JL et al (2011) Procalcitonin and C-reactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients. Crit Care 15(2):R78
18. Meng XN, Li N, Guo DZ et al (2014) High plasma glutamate levels are associated with poor functional outcome in acute ischemic stroke. Cell Mol Neurobiol. doi:10.1007/s10571-014-0107-0
19. Mimoz O, Edouard AR, Samii K et al (1998) Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 24:185–188
20. Rost NS, Wolf PA, Kase CS et al (2001) Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32:2575–2579
21. Schiopu A, Hedblad B, Engström G et al (2012) Plasma procalcitonin and the risk of cardiovascular events and death: a prospective population-based study. J Intern Med 272:484–491
22. Simon L, Gauvin F, Amre DK et al (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206–217
23. Slot KB, Berge E, Dorman P et al (2008) Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ 336:376–379
24. Szabo K, Kern R, Gass A et al (2001) (2001) Acute stroke patterns in patients with internal carotid artery disease: a diffusion-weighted magnetic resonance imaging study. Stroke 32:1323–1329
25. Tamaki K, Kogata Y, Sugiyama D et al (2008) Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases. J Rheumatol 35:114–119
26. Tu WJ, Dong X, Zhao SJ et al (2013) Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke. J Neuroendocrinol 25:771–778
27. Vibo R, Kõrv J, Roose M et al (2007) Free Radic Res. Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome. Free Radic Res 41:282–287
28. Wang Y, Ji H, Tong Y et al (2014) Prognostic value of serum 25-hydroxyvitamin D in patients with stroke. Neurochem Res 39:1332–1337
29. Wanner GA, Keel M, Steckholzer U et al (2000) Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 28:950–957
30. Wheeler AP, Bernard GR (1999) Treating patients with severe sepsis. N Engl J Med 340:207–214
31. Whiteley W, Chong WL, Sengupta A et al (2009) Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke 40:e380–e389
32. Whiteley W, Wardlaw J, Dennis M et al (2012) The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke 43:86–91